NCT07330427 Impact of Health Education on Knowledge, Attitude and Practice of Post-exposure Prophylaxis
| NCT ID | NCT07330427 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aswan University |
| Condition | Post Exposure Prophylaxis |
| Study Type | INTERVENTIONAL |
| Enrollment | 340 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 340 participants in total. It began in 2025-06-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Occupational exposure to blood-borne pathogens, such as human immune-deficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) for healthcare workers through contact with human blood and body fluids has become a major health concern as it poses a risk of transmission of these infectious agents. According to the World Health Organization (WHO) report, about three million HCWs are exposed to blood-borne pathogens each year, of which 170,000 are exposed to HIV infections, 2 million to HBV infections, and 0.9 million to HCV infections. Most of the time, healthcare providers get exposure through the splash of blood or other body fluids into the eyes, nose, or mouth or nonintact skin exposure, and percutaneous injury occurs as a result of a break in the skin caused by a needlestick or sharps contaminated with blood or body fluids
Eligibility Criteria
Inclusion Criteria: 1. HCWs at the selected departments (physicians, nurses and housekeepers). 2. Age \>18 years old and below 60 years old in both Genders. 3. HCWs which have direct contact with blood and body fluids. Exclusion Criteria: 1. Age\<18 years old and above 60 years old. 2. Non-medical staff at Aswan university hospital. 3. Health care workers which have no contact with blood or body fluids.
Contact & Investigator
Shaimaa Sayed Abdelrheem, M.D
STUDY CHAIR
Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University
Frequently Asked Questions
Who can join the NCT07330427 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 55 Years, studying Post Exposure Prophylaxis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07330427 currently recruiting?
Yes, NCT07330427 is actively recruiting participants. Contact the research team at fatma.mahmoud@med.aswu.edu.eg for enrollment information.
Where is the NCT07330427 trial being conducted?
This trial is being conducted at Aswān, Egypt.
Who is sponsoring the NCT07330427 clinical trial?
NCT07330427 is sponsored by Aswan University. The principal investigator is Shaimaa Sayed Abdelrheem, M.D at Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University. The trial plans to enroll 340 participants.